Compounds > tibolone
Page last updated: 2024-08-16

tibolone and Uterine Prolapse

tibolone has been researched along with Uterine Prolapse in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blok, LJ; Burger, CW; Ewing, PC; Hanifi-Moghaddam, P; Klaassens, AH; Kloosterboer, HJ; Kooi, GS; Sijmons, B; Ten Kate-Booij, MJ; van Wijk, FH1
Blok, LJ; Boers-Sijmons, B; Burger, CW; den Bakker, MA; Hanifi-Moghaddam, P; Klaassens, AH; Kloosterboer, HJ; Ott, MC; Shipley, GL; van Wijk, FH; Verheul, HA1
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA1

Trials

3 trial(s) available for tibolone and Uterine Prolapse

ArticleYear
Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
    Fertility and sterility, 2006, Volume: 86, Issue:2

    Topics: Aged; Cell Proliferation; Drug Synergism; Endometrium; Estrogens; Female; Humans; Hysterectomy; Immunohistochemistry; Middle Aged; Mitosis; Norpregnenes; Postmenopause; Progestins; Uterine Prolapse

2006
Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.
    Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:5

    Topics: Cluster Analysis; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression; Gene Expression Profiling; Gene Regulatory Networks; Humans; Hysterectomy, Vaginal; Medroxyprogesterone; Norpregnenes; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Postmenopause; Reproducibility of Results; RNA, Messenger; Sex Hormone-Binding Globulin; Signal Transduction; Uterine Prolapse

2007
Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
    Reproductive sciences (Thousand Oaks, Calif.), 2007, Volume: 14, Issue:2

    Topics: Aged; Estradiol; Estrone; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myometrium; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tissue Distribution; Uterine Prolapse; Vagina

2007